This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pacira Pharmaceuticals Inc (PCRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 37.52M 12.52M 10.13M 46.17M
Receivables 22.37M 14.59M 4.35M 2.11M
Inventories 29.26M 15.56M 12.08M 1.24M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 214.26M 106.75M 60.92M 82.65M
Property, Plant & Equipment, Gross 80.75M 60.76M 50.72M 33.38M
Accumulated Depreciation & Depletion 20.11M 12.58M 11.60M 8.28M
Property, Plant & Equipment, Net 60.63M 48.18M 39.12M 25.10M
Intangibles 403.00K 1.16M 3.21M 5.26M
Other Non-Current Assets 27.02M 3.40M 511.00K 479.00K
Total Non-Current Assets 111.82M 63.07M 51.13M 30.84M
Liabilities & Shareholder Equity
Total Assets 326.07M 169.82M 112.05M 113.49M
Accounts Payable 6.76M 3.07M 2.57M 3.44M
Short Term Debt 276.00K 0.00 0.00 8.26M
Other Current Liabilities 139.00K 1.02M 823.00K 0.00
Total Current Liabilities 140.01M 121.94M 14.16M 31.91M
Long Term Debt 0.00 0.00 25.19M 18.54M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 14.92M 6.63M 6.85M 13.24M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 14.92M 6.63M 32.04M 33.31M
Total Liabilities 154.93M 128.57M 46.20M 65.22M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 171.14M 41.25M 65.86M 48.27M
Common Par 36.00K 34.00K 33.00K 25.00K
Additional Paid In Capital 481.33M 337.64M 298.32M 228.47M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -310.14M -296.43M -232.52M -180.24M
Treasury Stock 0.00 0.00 -2.00K -2.00K
Other Equity Adjustments -80.00K 5.00K 27.00K 15.00K
Total Capitalization 171.14M 41.25M 91.05M 66.81M
Total Equity 171.14M 41.25M 65.86M 48.27M
Total Liabilities & Stock Equity 326.07M 169.82M 112.05M 113.49M
Total Common Shares Outstanding 36.15M 33.64M 32.62M 25.34M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 1.06K 1.06K
Basic Weighted Shares Outstanding 35.30M 33.18M 30.33M 16.44M
Diluted Weighted Shares Outstanding 35.30M 33.18M 30.33M 16.44M
Number of Employees 447 308 133 131
Number of Part-Time Employees 0 2 0 2
PCRX News

PCRX Pacira Pharmaceuticals Inc

Chart of PCRX

Analysts Ratings for PCRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 2 2 1 0
Moderate Sell 0 0 1 1
Strong Sell 0 0 0 0
GET PCRX ANALYST REPORT

Brokerage Partners

PCRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs